Study Reveals ADHD Drugs Do Not Improve Cognition in Healthy College Students
Published : 2018-07-28
Author : University of Rhode Island - Contact: uri.edu
🛈 Synopsis : Contrary to popular belief across college campuses, attention deficit hyperactivity disorder medications may fail to improve cognition in healthy students and actually can impair functioning.
Contrary to popular belief across college campuses, attention deficit hyperactivity disorder (ADHD) medications may fail to improve cognition in healthy students and actually can impair functioning, according to a study by researchers at the University of Rhode Island and Brown University.
Study co-investigators Lisa Weyandt, professor of psychology and a faculty member with URI's George and Anne Ryan Institute for Neuroscience, and Tara White, assistant professor of research in behavioral and social sciences at Brown University, had anticipated different findings.
"We hypothesized that Adderall would enhance cognition in the healthy students, but instead, the medication did not improve reading comprehension or fluency, and it impaired working memory," she said. "Not only are they not benefitting from it academically, but it could be negatively affecting their performance."
This first-ever multisite pilot study of the impact of so-called "study drugs" on college students who do not have ADHD comes at a time when use of prescription stimulants such as Adderall, Ritalin and Vyvanse is common among young adults who believe the drugs will improve their academic performance.
Research by Weyandt and others has estimated that 5 to 35 percent of college students in the United States and European countries without ADHD illegally use these controlled substances, buying or receiving them from peers, friends, or family.
Assortment of multi-colored pills and capsules.
Results of the new study, published last month in the journal Pharmacy, show that the standard 30 mg dose of Adderall did improve attention and focus - a typical result from a stimulant - but that effect failed to translate to better performance on a battery of neurocognitive tasks that measured short-term memory, reading comprehension and fluency.
Weyandt has a theory about why working memory would be adversely affected by the medication.
Brain scan research shows that a person with ADHD often has less neural activity in the regions of the brain that control executive function - working memory, attention, self-control. For people with ADHD, Adderall and similar medications increase activity in those regions and appear to normalize functioning. "If your brain is functioning normally in those regions, the medication is unlikely to have a positive effect on cognition and my actually impair cognition. In other words, you need to have a deficit to benefit from the medicine," Weyandt said.
Participants in the study also reported their perceived effects of the drug and its impact on their emotions, with students reporting significant elevation of their mood when taking Adderall.
In contrast to the small, mixed effects on cognition, the drug had much larger effects on mood and bodily responses, increasing positive mood, emotional ratings of the drug effect, heart rate and blood pressure.
"These are classic effects of psychostimulants," said White. "The fact that we see these effects on positive emotion and cardiovascular activity, in the same individuals for whom cognitive effects were small or negative in direction, is important. It indicates that the cognitive and the emotional impact of these drugs are separate. How you feel under the drug does not necessarily mean that there is an improvement in cognition; there can be a decrease, as seen here in young adults without ADHD."
The physical effects from the drugs, such as increased heart rate and blood pressure, were expected, and underscored the difference with cognition.
"They are subjecting themselves to physiological effects but do not appear to be enhancing their neurocognition," Weyandt said. She stressed, however, that the findings are based on a pilot study and need to be replicated with a substantially larger sample of college students.
The researchers recruited students from both universities, eliminating individuals who had taken ADHD medications or other drugs. After rigorous health screenings, 13 students participated in two five-hour sessions at White's lab at Brown and at Memorial Hospital in Pawtucket.
In the double-blind study, in which neither researchers nor participants know who is receiving the placebo and who is receiving the study medication, each student received Adderall in one session and the placebo in the other. This allowed the researchers to see the effects of the medication vs. placebo in individuals and across the group.
Given the important and unexpected results from the study, Weyandt and White plan to apply for federal funding to continue the research with a larger group of healthy college students.
This research was supported by grants from the Rhode Island Neuroscience Collaborative, the Brown (now Carney) Institute for Brain Science, the George and Anne Ryan Institute for Neuroscience and the Norman Prince Neurosciences Institute at Rhode Island Hospital as well as divisions within the National Institutes of Health and the National Science Foundation.
Disabled World Editor:
Nootropics: Smart Drug Intelligence Enhancer Supplements - Information on smart drugs, also known as Nootropics or intelligence enhancers, used to improve brain mental function.
Source/Reference: University of Rhode Island (uri.edu). Disabled World makes no warranties or representations in connection therewith. Content may have been edited for style, clarity or length.
Related Pharmaceutical Documents
- 1: Adherence to Prescription Medications : People in America are not benefiting from treatment advances because of persistent issue of poor prescription medication adherence.
- 2: SMA1 Infant Life-Saving Zolgensma Therapy Unavailable in Canada : Ground-breaking new drug Zolgensma that could stop progression of Spinal Muscular Atrophy Type 1 (SMA1) is the most expensive medication in the world.
- 3: How to Save Money on Prescription Medications : Information on ways you can save money on your prescription medication needs.
- 4: Biosimilar Drugs May Save Health Care Billions : Bio-similar versions of complex biologic drugs used to treat illnesses such as cancer and rheumatoid arthritis could cut spending on biologics in U.S. by $44 billion.
- 5: Antibiogram Use in Nursing Facilities May Help Improve Antibiotic Use and Effectiveness : Study shows use of antibiograms in skilled nursing facilities could improve antibiotic effectiveness and help address problems with antibiotic resistance.
You're reading Disabled World. Be sure to check out our homepage for further informative disability news, reviews, exclusive stories and how-tos. You can also follow Disabled World on social media sites such as Twitter, Facebook, and LinkedIn.
Disclaimer: Disabled World provides general information only. Materials presented are in no way meant to be a substitute for professional medical care by a qualified practitioner, nor should they be construed as such. Any 3rd party offering or advertising on disabled-world.com does not constitute endorsement by Disabled World. View our Advertising Policy for further information. Please report outdated or inaccurate information to us.
Journal: Disabled World. Language: English (U.S.). Author: University of Rhode Island. Electronic Publication Date: 2018-07-28. Title: Study Reveals ADHD Drugs Do Not Improve Cognition in Healthy College Students, Source: <a href=https://www.disabled-world.com/medical/pharmaceutical/adderall.php>Study Reveals ADHD Drugs Do Not Improve Cognition in Healthy College Students</a>. Retrieved 2021-04-12, from https://www.disabled-world.com/medical/pharmaceutical/adderall.php - Reference: DW#269-13502.